Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus

Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus

ObjectiveThis study aimed to identify the association between specific short-chain acylcarnitines and cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM).MethodWe retrieved 1,032 consecutive patients with T2DM who meet the inclusion and exclusion criteria from the same tertiary care cent...

Full description

Bibliographic Details
Main Authors: Shuo Zhao, Ming-Li Liu, Bing Huang, Fu-Rong Zhao, Ying Li, Xue-Ting Cui, Rong Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Endocrinology
Subjects:
type 2 diabetes mellitus
cardiovascular disease
acylcarnitine
metabolism
relationship
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.806819/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.806819/full

Similar Items